a double-blind cross-over trial over 24 weeks ( 10 weeks on the active remedy , 4 weeks off treatment , and 10 weeks on placebo ) of the effect of l-dopa on idiopathic parkinsonism ( paralysis agitans ) has shown no difference in the response obtained in patients who had undergone previous stereotaxic ventrolateral thalamotomy and in those who had not .
C0023570
l-dopa
C0030567
paralysis agitans